According to Redhill Biopharma's latest financial reports the company's current earnings are HK$35.74 Million. In 2022 the company made an earning of -HK$0.56 Billion, an increase over its 2021 earnings that were of -HK$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.